< em > CD6 < /em > and < em > CCR7 < /em > as Genetic Biomarkers in Evaluating Intracranial Aneurysm Rupture Risk

CONCLUSIONS: The identified two-gene signature (CD6-CCR7) for evaluating the risk of IA rupture demonstrated good clinical application value.PMID:38538213 | DOI:10.31083/j.jin2303055
Source: Journal of Integrative Neuroscience - Category: Neuroscience Authors: Source Type: research